Device-related infections: A review

Journal of Long-Term Effects of Medical Implants

Volumn 15, Issue 5, 2005, Pages 467-488

  Vinh, Donald C ^a   Embil, John M ^a,b,c,d  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Health Sciences Centre   (Canada)

^c WINNIPEG REGIONAL HEALTH AUTHORITY   (Canada)

^d Diabetic Foot and Complicated Wound Clinic   (Canada)

Author keywords

Biofilm; Cochlear implant; Device; Implant; Implanted cardioverter defibrillators; Infection; Intraspinal pumps; Meningitis; Neurostimulators; Prosthesis; Prosthetic cardiac valves; Transvenous pacemakers; Ventriculars assist devices; Ventriculoperitoneal shunt

Indexed keywords

DEVICE; INFECTION; QUALITY OF LIFE;

ANTIBIOTICS; BIOFILMS; HEALTH CARE; IMMUNOLOGY;

IMPLANTS (SURGICAL);

ANTIINFECTIVE AGENT;

BACTERIAL COLONIZATION; BIOFILM; BREAST; CLINICAL EXAMINATION; CLINICAL FEATURE; COCHLEA PROSTHESIS; DEVICE INFECTION; DIAGNOSTIC VALUE; DISEASE SEVERITY; HEALTH CARE COST; HEALTH CARE SYSTEM; HEART SURGERY; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; IMPLANT; MORBIDITY; MORTALITY; NEUROSURGERY; ORTHOPEDIC EQUIPMENT; PENIS PROSTHESIS; PHENOTYPE; PROSTHESIS LOOSENING; QUALITY OF LIFE; REVIEW; SALVAGE THERAPY; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT INDICATION; WOUND DEHISCENCE;

ANTI-BACTERIAL AGENTS; DEVICE REMOVAL; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INCIDENCE; MALE; PROGNOSIS; PROSTHESES AND IMPLANTS; PROSTHESIS-RELATED INFECTIONS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 27844574667     PISSN: 10506934     EISSN: None     Source Type: Journal    
DOI: 10.1615/JLongTermEffMedImplants.v15.i5.20     Document Type: Review

References (108)

1. Darouiche RO. Antimicrobial approaches for preventing infections associated with surgical implants. Clin Infect Dis. 2003;36:1284-9.
2. Whitehouse JD, Friedman ND, Kirkland KB, Richardson WJ, Sexton DJ. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol. 2002;23(4):183-9.
3. Jefferson KK. What drives bacteria to produce a biofilm? FEMS Microbiol Lett. 2004;236:163-73.
4. Donlan RM. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis. 2001;33:1387-92.
5. Schmidt AH, Swiontkowski MF. Pathophysiology of infections after internal fixation of fractures. J Am Acad Orthop Surg. 2000;8(5):285-91.
6. von Eiff C, Heilmann C, Peters G. New aspects in the molecular basis of polymer-associated infections due to Staphylococci. Eur J Clin Microbiol Infect Dis. 1999;18:843-6.
7. Peters K, Schmidt H, Unger RE, Otto M, Kamp G, Kirkpatrick CJ. Software-supported image quantification of angiogenesis in an in vitro culture system: application to studies of biocompatibility. Biomaterials. 2002;23(16):3413-9.
8. Hausman MR, Rinker BD. Intractable wounds and infections: the role of impaired vascularity and advanced surgical methods for treatment. Am J Surg. 2004;187(5A):44S-55S.
9. Tresse O, Jouenne T, Junter GA. The role of oxygen limitation in the resistance of agar-entrapped, sessile-like Escherichia coli to aminoglycoside and Beta-lactam antibiotics. J Antimicrob Chemother. 1995;36:521-6.
10. Voth D. Perioperative prevention of infection in neurosurgery. Antibiot Chemother. 1985;33:165-183.
11. Cardona-Bonet LL, Cortes A. Management of perioperative infectious complications in the neurologic patient. Neurol Clin. 2004;22(2):329-45.
12. Kernodle DS, Kaiser AB. Chapter 308: Postoperative infections and antimicrobial prophylaxis. In: Mandell, editor. Principles and practice of infectious diseases, vol 2. Philadelphia: Churchill Livingstone; 2000.
13. Brook I. Meningitis and shunt infection caused by anaerobic bacteria in children. Pediatr Neurol. 2002;26(2):99-105.
14. Morris A, Low DE. Nosocomial bacterial meningitis, including central nervous system shunt infections. Infect Dis Clin North Am. 1999;13(3):735-50.
15. George R, Leibrock L, Epstein M. Long term analysis of cerebrospinal fluid shunt infections. A 25 year experience. J Neurosurg. 1979;51:804-11.
16. Ammirati M, Raidmondi AJ. Cerebrospinal fluid shunt infections in children: a study on the relationship between the etiology of hydrocephalus, age at the time of shunt placement, and infection rate. Childs Nerv Syst. 1987;3:106-9.
17. Serlo W, Fernell E, Heikkinen E, Anderson H, von Wendt L. Functions and complications of shunts in different etiologies of childhood hydrocephalus. Childs Nerv Syst. 1990;6:92-4.
18. Renier D, Lacombe J, Pierre-Kahn A, Sainte-Rose C, Hirsch JF. Factors causing acute shunt infection: computer analysis of 1174 operations. J Neurosurg. 1984;61:1072-8.
19. Mancao M, Miller C, Cochrane B, Hoff C, Sauter K, Weber E. Cerebrospinal fluid shunt infections in infants and children in Mobile, Alabama. Acta Paediatr. 1998;87:667-0.
20. Kontny U, Hofling B, Gutjahr P, Voth D, Schwarz M, Schmitt HJ. CSF shunt infections in children. Infection. 1993;21:89-92.
21. McGirt MJ, Zaas A, Fuchs HE, George TM, Kaye K, Sexton DJ. Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis. 2003;36:858-62.
22. Tunkel AR, Scheld W. Acute Meningitis. In: Mandell GL, Bennett JE, Dolin R, editor. Principles and practice of infectious diseases, vol 2. Philadelphia: Churchill Livingstone; 2000.
23. Schoenbaum SC, Gardner P, Shilliton J. Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy. J Infect Dis. 1975;131:543-52.
24. Bell WO. Management of infected cerebrospinal fluid shunts in children. Contemp Neurosurg. 1992;14:6-16.
25. Lyke KE, Obasanjo O, Williams MA, O'Brien M, Chotani R, Perl TM. Ventriculitis complicating use of intraventricular catheters in adult neurosurgical patients. Clin Infect Dis. 2001;33(12):2028-33.
26. Rodriguez WJ, Khan W, Cocchetto DM, Feris J, Puig JR, Akram S. Treatment of Pseudomonas meningitis with ceftazidime with or without concurrent therapy. Ped Infect Dis J. 1990;9:83-7.
27. Nguyen MH, Harris SP, Muder RR, Pasculle AW. Antibiotic-resistant Acinetobacter meningitis in neurosurgical patients. Neurosurgery. 1994;35(5):851-5.
28. Strand CL, Dubois R. Propionibacterium acnes central nervous system shunt infection. Commercial blood culture medium-dependent isolation of the bacterium. Am J Clin Pathol. 1981;75(5):743-6.
29. Forward KR, Fewer HD, Stiver HG. Cerebrospinal fluid shunt infection. A review of 35 infections in 32 patients. J Neurosurg. 1983;59:389-94.
30. Brown EM for the Infection in Neurosurgery Working Party of the British Society for Antimicrobial Chemotherapy. The management of neurosurgical patients with postoperative bacterial or aseptic meningitis or external ventricular drain-associated ventriculitis. Br J Neurosurg. 2000;14(1):7-12.
31. Byers K, Axelrod P, Michael S, Rosen S. Infections complicating tunneled intraspinal catheter systems used to treat chronic pain. Clin Infect Dis. 1995;21:403-8.
32. Follett KA, Boortz-Marx R, Drake JM, DuPen S, Schneider SJ, Turner MS, Coffey RJ. Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections. Anesthesiology. 2004;100(6):1582-94.
33. Gates GA, Miyamoto R. Cochlear implants. N Engl J Med. 2003;349(5):421-3.
34. Cunningham DC, Slattery WH, Luxford WM. Postoperative infection in cochlear implant patients. Otolaryngol Head Neck Surg. 2004;131:109-14.
35. Kempf HG, Johann K, Lenarz T. Complications in pediatric cochlear implant surgery. Eur Arch Otorhinolaryngol. 1999;256(3):128-32.
36. Yu KCY, Hegarty J, Gantz BJ, Lalwani AK. Conservative management of infections in cochlear implant recipients. Otolaryngol Head Neck Surg. 2001;125(1):66-70.
37. Green KM, Bhatt Y, Saeed SR, Ramsden RT. Complications following adult cochlear implantation: experience in Manchester. J Laryngol Otol. 2004;118(6):417-20.
38. Reefhuis J, Honein MA, Whitney CG, et al. Risk of bacterial meningitis in children with cochlear implants. N Engl J Med. 2003;349(5):435-45.
39. Callanan V, Poje C. Cochlear implantation and meningitis. Int J Pediatr Otorhinolaryngol. 2004;68(5):545-50.
40. Thamilarasan M, Griffin B. Choosing the most appropriate valve operation and prosthesis. CCJM. 2002;69(9):688-703.
41. Karchmer AW. Infections of prosthetic valves and intravascular devices. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 5th ed. vol 1. Philadelphia: Churchill Livingstone; 2000:903-11.
42. Karchmer AW, Longworth D. Infections of intracardiac devices. Cardiol Clin. 2003;21(2):253-71.
43. Karchmer AW. Infective endocarditis. In: Braunwald, editor. Heart disease: a textbook of cardiovascular medicine. 6th ed. Philadelphia: Saunders; 2001. pp. 1723-45.
44. Giamarellou H. Nosocomial cardiac infections. J Hosp Infect. 2002;50:91-105.
45. Sexton DJ, Spelman D. Current best practices and guidelines: assessment and management of complications of infective endocarditis. Cardiol Clin. 2003;21(2):273-82.
46. Calderwood SB, Swinski L, Karchmer AW, Waternaux CM, Buckley MJ. Prosthetic valve endocarditis, analysis of factors affecting outcome of therapy. J Thorac Cardiovasc Surg. 1986;92:776-83.
47. Gollob MH, Seger JJ. Current status of the implantable cardioverter-defibrillator. Chest. 2001;119(4):1210-21.
48. Chua JD, Wilkoff WL, Lee I, Juratli N, Longworth DL, Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Int Med. 2000;133(8):604-8.
49. Chamis AL, Peterson G, Cabell CH, Corey GR, Sorrentino RA, Greenfield RA, Ryan T, Reller LB, Fowler VG Jr. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation. 2001;104(9):1029-33.
50. Spratt KA, Blumberg EA, Wood CA, Kutalek SP, Reboli AC. Infections of implantable cardioverter defibrillators: approach to management. Clin Infect Dis. 1993;17:679-85.
51. Cacoub P, Leprince P, Nataf P, Hausfater P, Dorent R, Wechsler B, Bors V, Pavie A, Piette JC, Gandjbakhch I. Pacemaker infective endocarditis. Am J Cardiol. 1998;82(4):480-4.
52. Klug D, Lacroix D, Savoye C, Goullard L, Grandmougin D, Hennequin JL, Kacet S, Lekieffre J. Systemic infeciton related to endocarditis on pacemaker leads: clinical presentation and management. Circulation. 1997;95:2098-107.
53. Arber N, Pras E, Copperman Y, Schapiro JM, Meiner V, Lossos IS, Militianu A, Hassin D, Pras E, Shai A, et al. Pacemaker endocarditis. Report of 44 cases and review of the literature. Medicine. 1994;73:299-305.
54. Wilkoff BL. Pacemaker lead extraction with the laser sheath: results of the pacing lead extraction with the excimer sheath (PLEXES) trial. J Am Coll Cardiol. 1999;33(6):1671-6.
55. Lai KK, Fontecchio SA. Infections associated with implantable cardioverter defibrillators placed transvenously and via thoracotomies: epidemiology, infection control, and management. Clin Infect Dis. 1998;27:265-9.
56. Byrd CL. Management of implant complications. In: Ellenbogen KA, Kay GN, Wilkoff BL, editors. Clinical cardiac pacing and defibrillation. 2nd ed. Philadelphia: WB Saunders; 2000. pp. 669-94.
57. Hirsch DJ, Cooper J Jr. Cardiac failure and left ventricular assist devices. Anesthesiol Clin North Am. 2003;21(3):625-38.
58. Malani PN, Dyke DBS, Pagani FD, Chenowetch CE. Nosocomial infections in left ventricular assist device recipients. Clin Infect Dis. 2002;34:1295-300.
59. Rose EA, Gelijns AC, Moskowitz AJ, Arons R, Gupta L, Weinberg A, Faries PL, Nowygrod R, Kent KC. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435-443.
60. Sivaratnam K, Duggan J. Left ventricular assist device infections: three case reports and a review of the literature. ASAIO J. 2002;48:2-7.
61. Fischer SA, Trenholme GM, Costanzo MR, Piccione W. Infectious complications in left ventricular assist device recipients. Clin Infect Dis. 1997;24:18-23.
62. Goldstein DJ, el-Amir NG, Ashton RC Jr, Catanese K, Rose RA, Levin HR, Oz MC. Fungal infections in left ventricular assist device recipients. Incidence, prophylaxis, and treatment. ASAIO J. 1995;41(4):873-5.
63. Holman WL, Fix RJ, Foley BA, McGiffin DC, Rayburn BK, Kirklin JK. Management of wound and left ventricular assist device pocket infection. Ann Thorac Surg. 1999;68(3):1080-2.
64. Holman WL, Rayburn BK, McGiffin DC, Foley BA, Benza RL, Bourge RC, Pinderski LJ, Kirklin JK. Infection in ventricular assist devices: prevention and treatment. Ann Thorac Surg. 2003;75(S48-57).
65. McKellar SH, Allred BD, Marks JD, Cowley CG, Classen DC, Gardner SC, Long JW. LVAD pocket infection controlled with antibiotic-impregnated polymethylmethacrylate beads. Ann Thorac Surg. 1999;67:554-5.
66. Lutwick LJ, Vaghjimal A, Connolly MW. Postcardiac surgery infections. Critical Care Clin. 1998;14(2):221-50.
67. McCarthy PM, Schmitt SK, Vargo RL, Gordon S, Keys TF, Hobbs RE. Implantable LVAD infections: implications for permanent use of the device. Ann Thorac Surg. 1996;61:359-65.
68. Vilchez RA, McEllistrem MC, Harrison LH, McCurry KR, Kormos RL, Kusne S. Relapsing bacteremia in patients with ventricular assist device: an emergent complication of extended circulatory support. Ann Thorac Surg. 2001;72:96-101.
69. Nurozler F, Argenziano M, Oz MC, Naka Y. Fungal left ventricular assist device endocarditis. Ann Thorac Surg. 2001;71:614-8.
70. Prendergast TW, Todd BA, Beyer AJ 3rd, Furukawa S, Eisen HJ, Addonizio VP, Browne BJ, Jeevanandam V. Management of left ventricular assist device infection with heart transplantation. Ann Thorac Surg. 1997;64:142-7.
71. Morgan JA, Park Y, Oz MC, Naka Y. Device related infections while on left ventricular assist device support do not adversely impact bridging to transplant or posttransplant survival. ASAIO J. 2003;49(6):748-50.
72. Hutchinson OZ, Oz MC, Ascherman JA. The use of muscle flaps to treat left ventricular assist device infections. Plast Reconstr Surg. 2001;107(2):364-73.
73. De Cholnoky T. Augmentation mammaplasty: survey of complications in 10 941 patients by 265 surgeons. Plast Reconstr Surg. 1970;45:573-7.
74. Gabriel SE, Woods JE, O'Fallon WM, Beard CM, Kurland LT, Melton LJ 3rd. Complications leading to surgery after breast implantation. N Engl J Med. 1997;336(10):677-82.
75. Freedman A, Jackson I. Infections in breast implants. Infect Dis Clin North Am. 1989;3:275-287.
76. Ahn C, Ko C, Wagar E, Wong RS, Shaw WW. Microbial evaluation: 139 implants removed from symptomatic patients. Plast Reconstr Surg. 1996;98(7):1225-9.
77. Pajkos A, Deva AK, Vickery K, Cope C, Chang L, Cossart YE. Detection of subclinical infection in significant breast implant capsules. Plast Reconstr Surg. 2003;111(5):1605-11.
78. Darouiche RO, Meade R, Mansouri MD, Netscher DT. In vivo efficacy of antimicrobe-impregnated saline-filled silicone implants. Plast Reconstr Surg. 2002;109(4):1352-7.
79. Haiavy J, Tobin H. Mycobacterium fortuifum infection in prosthetic breast implants. Plast Reconstr Surg. 2002;109(6):2124-8.
80. Spear SL, Howard MA, Boehmler JH, Ducic I, Low M, Abbruzzesse MR. The infected or exposed breast implant: management and treatment strategies. Plast Reconstr Surg. 2004;113(6):1634-44.
81. Carson C.C. Reconstructive surgery using urologic prostheses. Curr Opin Urol. 1999;9:233-9.
82. Carson CC. Penile prosthesis implantation and infection for Sexual Medicine Society of North America. Int J Impot Res. 2001;13(Suppl 3): S35-8.
83. Licht MR, Montague DR, Angermier KW, Lakin MM. Cultures from genitourinary prostheses at reoperation: questioning the role of Staphylococcus epidermidis in periprosthetic infection. J Urol. 1995;154(2):387-90.
84. Blum MD. Infections of genitourinary prostheses. Inf Dis Ciln North Am. 1989;3:259-74.
85. Carson CC. Infections in gentiourinary prostheses. Urol Clin North Am. 1989;16:139-47.
86. Mulcahy JJ. Management of the infected penile implant-concepts on salvage techniques. Int J Impot Res. 1999;11(Suppl 1):S58-9.
87. Mulcahy JJ, Brant M, Ludlow JK. Management of infected penile implants. Tech Urol. 1995;1:115-9.
88. Mulcahy JJ. Treatment alternatives for the infected penile implant. Int J Impot Res. 2003;15(Suppl 5): S147-9.
89. Carson CC 3rd. Management of prosthesis infections in urologic surgery. Urol Clin North Am. 1999;26(4):829-39.
90. Parsons CL. Diagnosis and therapy of subclinically infected prostheses. Surg Gynecol Obstet. 1993;177(5):504-6.
91. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351(16):1645-54.
92. Berbari EF, Hanssen AD, Duffy MC, Steckelberg JM, Ilstrup DM, Harmsen WS, Osmon DR. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis. 1998;27:1247-54.
93. Gillespie WJ. Prevention and management of infection after total joint replacement. Clin Infect Dis. 1997;25:1310-7.
94. Widmer AF. New developments in diagnosis and treatment of infection in orthopedic implants. Clin Infect Dis. 2001;33(Suppl 2):S94-106.
95. Coventry MB. Treatment of infections occurring in total hip surgery. Orthop Clin North Am. 1975;6:991-1003.
96. Spangehl MJ, Younger AS, Masri BA, Duncan CP. Diagnosis of infection following total hip arthroplasty. Inst Course Lect. 1998;47:285-95.
97. Duan K, Fan Y, Wang R. Electrolytic deposition of calcium etidronate drug coating on titanium substrate. J Biomed Mater Res. 2004 Aug 17; Epub ahead of print.
98. Spangehl MJ, Masri BA, O'Connell JX, Duncan CP. Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infetion at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg Am. 1999;81:672-83.
99. Fitzgerald RJ. Infections of hip prosthesis and artifical joints. Inf Dis Clin North Am. 1989;3:329-38.
100. Sanderson PJ. Infection in orthopaedic implants. J Hosp Infect. 1991;18(Suppl A):367-75.
101. Zimmerli W, Ochsner PE. Management of infection assocaited with prosthetic joints. Infection. 2002;30(2):99-108.
102. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39(2):206-17.
103. Bernard L, Lubbeke A, Stern R, Bru JP, Feron JM, Peyramond D, Denormandie P, Arvieux C, Chirouze C, et al. Value of preoperative investigations in diagnosing prosthetic joint infection: retrospective cohort study and literature review. Scand J Infect Dis. 2004;36(6/7):410-6.
104. Atkins BL, Athanasou N, Decks JJ, Crook DW, Simpson H, Peto TE, McLardy-Smith P, Berendt AR. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. J Clin Microbiol 1998;36(10):2932-9.
105. Segreti J, Nelson JA, Trenholme GM. Prolonged suppressive antibiotic therapy for infected orthopedic prostheses. Clin Infect Dis. 1998;27:711-3.
106. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004;350(14):1422-9.
107. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of riampin for treatment of orthopedic implant-related staphylococcal infection. JAMA. 1998;279(19):1537-41.
108. Drancourt M, Stein A, Argenson JN, Roiron R, Groulier P, Raoult D. Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin. J Antimicrob Chemother. 1997;39:235-40.